4538 — Fuso Pharmaceutical Industries Share News
0.000.00%
Last trade - 00:00Table: Fuso Pharmaceutical -2025/26 parent results
Table: Fuso Pharmaceutical - 9-MTH parent results
Table: Fuso Pharmaceutical - 6-MTH parent results
Table: Fuso Pharmaceutical - Q1 parent results
Table: Fuso Pharmaceutical -2024/25 parent results
Table: Fuso Pharmaceutical -2024/25 parent results
Table: Fuso Pharmaceutical - 9-MTH parent results
Brief: Dimerix And FUSO Enter Into Exclusive Development And License Agreement To Commercialise DMX-200 In Japan
Australia's Dimerix jumps most in 1 year on drug development agreement for Japan
Table: Fuso Pharmaceutical - 6-MTH parent results
2024 6-month parent forecast
Table: Fuso Pharmaceutical - Q1 parent results
Table: Fuso Pharmaceutical -2023/24 parent results
Table: Fuso Pharmaceutical - 9-MTH parent results
Table: Fuso Pharmaceutical - 6-MTH parent results
To Buy Back Up To 3.88% Of Shares Worth 735 Million Yen On Wednesday Via ToSTNeT-3
Table: Fuso Pharmaceutical - Q1 parent results
Table: Fuso Pharmaceutical -2022/23 parent results
Table: Fuso Pharmaceutical - 9-MTH parent results